Conference Proceedings

Interim results of a Phase I/II prospective dose escalation trial evaluating safety and efficacy of combination Lu-177 PSMA 617 and NOX66 in men with mCRPC post androgen signalling inhibition and 2 lines of taxane chemotherapy (LuPIN trial)

Louise Emmett, Megan Crumbaker, Andrew Nguyen, Bao Ho, Charlotte Yin, Noah Isheish, Arun Azad, John Violet, Shikha Sharma, Anthony Joshua

JOURNAL OF NUCLEAR MEDICINE | SOC NUCLEAR MEDICINE INC | Published : 2019